About the Authors
- Siyu Wang
-
Contributed equally to this work with: Siyu Wang, Stephanie M. Reeve, Graham T. Holt, Adegoke A. Ojewole
Roles Investigation, Software, Writing – original draft
Affiliations Department of Computer Science, Duke University, Durham, North Carolina, United States of America, Program in Computational Biology and Bioinformatics, Duke University, Durham, North Carolina, United States of America
- Stephanie M. Reeve
-
Contributed equally to this work with: Siyu Wang, Stephanie M. Reeve, Graham T. Holt, Adegoke A. Ojewole
Roles Investigation
Affiliation Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, United States of America
- Graham T. Holt
-
Contributed equally to this work with: Siyu Wang, Stephanie M. Reeve, Graham T. Holt, Adegoke A. Ojewole
Roles Investigation, Software, Writing – review & editing
Affiliations Department of Computer Science, Duke University, Durham, North Carolina, United States of America, Program in Computational Biology and Bioinformatics, Duke University, Durham, North Carolina, United States of America
- Adegoke A. Ojewole
-
Contributed equally to this work with: Siyu Wang, Stephanie M. Reeve, Graham T. Holt, Adegoke A. Ojewole
Roles Investigation, Software
Current address: Genentech, Inc., San Francisco, California, United States of America
Affiliations Department of Computer Science, Duke University, Durham, North Carolina, United States of America, Program in Computational Biology and Bioinformatics, Duke University, Durham, North Carolina, United States of America
- Marcel S. Frenkel
-
Roles Investigation
Affiliation Department of Biochemistry, Duke University Medical Center, Durham, North Carolina, United States of America
- Pablo Gainza
-
Roles Conceptualization
Affiliation Department of Computer Science, Duke University, Durham, North Carolina, United States of America
- Santosh Keshipeddy
-
Roles Investigation
Affiliation Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, United States of America
- Vance G. Fowler
-
Roles Conceptualization
Affiliation Division of Infections Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America
- Dennis L. Wright
-
Roles Conceptualization, Funding acquisition, Resources, Supervision
Affiliations Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, United States of America, Department of Chemistry, University of Connecticut, Storrs, Connecticut, United States of America
- Bruce R. Donald
-
Roles Conceptualization, Funding acquisition, Resources, Software, Supervision, Writing – original draft, Writing – review & editing
* E-mail: brd+pcb21@cs.duke.edu
Affiliations Department of Computer Science, Duke University, Durham, North Carolina, United States of America, Department of Biochemistry, Duke University Medical Center, Durham, North Carolina, United States of America, Department of Mathematics, Duke University, Durham, North Carolina, United States of America, Department of Chemistry, Duke University, Durham, North Carolina, United States of America
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: B.R.D. and M.S.F. are founders of Ten63 Therapeutics. V.G.F. reports personal fees (consultancy) from Novartis, Novadigm, Durata, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., Cerexa, Tetraphase, Trius, MedImmune, Bayer, Theravance, Basilea, Affinergy, Janssen, xBiotech, Contrafect, Regeneron, Basilea, Destiny, Amphliphi Biosciences, Integrated Biotherapeutics, C3J. V.G.F. has grants received or pending to his institution from following entities: NIH, MedImmune, Cerexa, Forest, Actavis, Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Cubist, Merck, Medical Biosurfaces, Locus, Affinergy, Contrafect, Karius, Genentech, Regeneron, Basilea, Janssen. V.G.F. received educational fees from Green Cross, Cubist, Cerexa, Durata, Theravance, Debiopharm. V.G.F. received royalties from UpToDate. V.G.F. has a pending patent on host gene expression signature diagnostic for sepsis. B.R.D. was previously a guest editor for PLoS Comp. Biol.